Uncategorized

India goldilocks phase

India’s 2025 Goldilocks Phase: High Growth, Low Inflation and strong Economic Strength

/ Uncategorized /

India is set to conclude 2025 on one of its strongest macroeconomic footings in recent history, marked by robust economic growth, sharply easing inflation, improving employment conditions, and rising global confidence. Government data, supported by projections from leading global institutions, point to a rare alignment of growth and stability often described as a “Goldilocks phase” […]

India’s 2025 Goldilocks Phase: High Growth, Low Inflation and strong Economic Strength Read More »

H-1b visa and IT stocks

IT Stocks Slip as US Ends H-1B Visa Lottery, Moves to Skill-Weighted System

/ Global Market​​, Indian Market, Uncategorized /

Indian IT companies edged lower on December 24 after the United States announced a major overhaul of its H-1B visa for work allocation system, replacing the long-standing lottery mechanism with a weighted selection process that prioritises higher-paid and more skilled foreign workers. Stocks such as Coforge, Tech Mahindra and Wipro declined between 0.7% and 1%,

IT Stocks Slip as US Ends H-1B Visa Lottery, Moves to Skill-Weighted System Read More »

Ambuja-Acc-Orient-merger.

Ambuja–ACC–Orient Cement Merger to Reshape India’s Cement Landscape: Key Takeaways

/ Uncategorized /

Ambuja Cements has set the stage for a major consolidation in India’s cement sector, with the boards of ACC and Orient Cement approving their merger into Ambuja. Once completed, the transaction is expected to create one of the country’s most integrated and geographically diversified cement platforms. The merger process is likely to take up to

Ambuja–ACC–Orient Cement Merger to Reshape India’s Cement Landscape: Key Takeaways Read More »

INDIA-NEW-ZEALAND-FREE-TRADE-AGREEMENT

India–New Zealand FTA Concluded: 95% of Tariffs to be Slashed

/ Uncategorized, Global Market​​, Indian Market /

India and New Zealand have successfully concluded a Free Trade Agreement (FTA), an achievement notable for being one of India’s quickest trade deals with a developed economy. This agreement is set to significantly enhance bilateral trade, boost investment, and strengthen people-to-people connections between the two nations. Key Trade Liberalization The agreement features substantial market access

India–New Zealand FTA Concluded: 95% of Tariffs to be Slashed Read More »

ICICI Prudential AMC Emerges as the Most Valuable Capital Market Stock After 19% surge

/ Uncategorized /

Indian Markets | IPO Watch  ICICI Prudential Asset Management Company(ASM) delivered a strong debut on Dalal Street, emerging as the most valuable company within India’s capital market ecosystem after its stock surged sharply on the first day of listing. The shares jumped over 23 percent during intraday trade, touching a high of ₹2,663, before closing

ICICI Prudential AMC Emerges as the Most Valuable Capital Market Stock After 19% surge Read More »

Infosys surge 40%

Infosys ADR Surge 40% After Rare Short Squeeze, Trading Halt Triggered in US

/ Must Read, Uncategorized /

Indian IT major Infosys Ltd’s American Depository Receipt (ADR) witnessed an exceptional spike in US trading on December 19, driven purely by a technical short squeeze, not by any fundamental trigger. The Infosys ADR surged as much as 40% intraday, touching a 52-week high, before volatility controls led to a temporary trading halt. At around

Infosys ADR Surge 40% After Rare Short Squeeze, Trading Halt Triggered in US Read More »

Indian pharma stock rise after Biosecure act

Pharma Stocks surge After US Senate Passes Biosecure Act; Nifty Pharma Gains

/ Indian Market, Global Market​​, Uncategorized /

Pharmaceutical stocks surged on December 19 after the US Senate passed the Biosecure Act as part of the fiscal 2026 National Defense Authorization Act (NDAA), a move seen as structurally positive for Indian drug makers. The rally pushed the Nifty Pharma index up 0.65% to 22,704, after hitting an intraday high of over 1.35%. Investor

Pharma Stocks surge After US Senate Passes Biosecure Act; Nifty Pharma Gains Read More »

Gujarat Kidney & Super Speciality

Details of Gujarat Kidney & Super Speciality Limited IPO : Lot Size, Check Issue Date, Price

/ Uncategorized, IPO News /

Gujarat Kidney & Super Speciality IPO Price: ₹108 to ₹114 per share IPO Dates: 22nd December 2025 – 24th December 2025 Company Overview Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispeciality healthcare provider offering secondary and tertiary care services across multiple locations in Gujarat, India. Hospital Network & Infrastructure The

Details of Gujarat Kidney & Super Speciality Limited IPO : Lot Size, Check Issue Date, Price Read More »

ICICI Prudential Asset Management Co. Limited IPO

Details of ICICI Prudential Asset Management Co. Limited IPO : Lot Size, Check Issue Date, Price

/ Uncategorized, IPO News /

ICICI Prudential Asset Management Co. IPO Price: ₹2061 to ₹2165 per share IPO Dates: 12th December 2025 – 16th December 2025 Company Overview Incorporated in 1993, ICICI Prudential AMC is one of India’s leading Asset Management Companies. The company follows a risk-first investment approach with a long-term return objective for its customers. Assets Under Management

Details of ICICI Prudential Asset Management Co. Limited IPO : Lot Size, Check Issue Date, Price Read More »

Details of Park Medi World Limited IPO : Lot Size, Check Issue Date, Price

/ Uncategorized, IPO News /

Park Medi World Health Services IPO Price: ₹154 to ₹162 per share IPO Dates: 10th December 2025 – 12th December 2025 Company Overview Incorporated in 2011, Park Medi World Limited is a leading private hospital chain primarily operating in North India. As of March 31, 2025, the company has a total bed capacity of 3,000

Details of Park Medi World Limited IPO : Lot Size, Check Issue Date, Price Read More »

Scroll to Top